Immunoglobulin G: A useful outcome marker in the follow-up of cystic fibrosis patients?

Hanssens, Laurence S; Cellauro, Sarah; Duchateau, Jean; Casimir, Georges J

Hanssens, Laurence S; Cellauro, Sarah; Duchateau, Jean; Casimir, Georges J.

Afiliação

Hanssens LS; Department of Pediatric Pulmonology and Cystic Fibrosis Clinic, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Cellauro S; Department of Pediatric Pulmonology and Cystic Fibrosis Clinic, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Duchateau J; Laboratoire Académique de Pédiatrie, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
Casimir GJ; Department of Pediatric Pulmonology and Cystic Fibrosis Clinic, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.

Immun Inflamm Dis ; 9(2): 608-614, 2021 06.

Article em En | MEDLINE | ID: mdl-33783131

Assuntos

Fibrose Cística; Criança; Fibrose Cística/diagnóstico; Fibrose Cística/epidemiologia; Seguimentos; Humanos; Imunoglobulina G; Lactente; Estudos Longitudinais; Pseudomonas aeruginosa

Palavras-chave

children; cystic fibrosis; hypergammaglobulinemia; hypogammaglobulinemia; immunoglobulins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google